ticlopidine has been researched along with Postthrombotic Syndrome in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Postthrombotic Syndrome: A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA; PAIN; aching; heaviness; and MUSCLE CRAMP in the leg. When severe leg swelling leads to skin breakdown, it is called venous STASIS ULCER.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belcaro, G | 1 |
Dugall, M | 1 |
Hu, S | 1 |
Feragalli, B | 1 |
Cotellese, R | 1 |
Ledda, A | 1 |
Corsi, M | 1 |
Ricci, A | 1 |
Ippolito, E | 1 |
Errichi, BM | 1 |
Cornelli, U | 1 |
Cesarone, MR | 1 |
Hosoi, M | 1 |
Langwieser, N | 1 |
Bernlochner, I | 1 |
Wustrow, I | 1 |
Dirschinger, RJ | 1 |
Jaitner, J | 1 |
Dommasch, M | 1 |
Bradaric, C | 1 |
Laugwitz, KL | 1 |
Ibrahim, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting[NCT04694248] | 172 participants (Anticipated) | Interventional | 2021-11-03 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ticlopidine and Postthrombotic Syndrome
Article | Year |
---|---|
Combination of factor Xa inhibition and antiplatelet therapy after stenting in patients with iliofemoral post-thrombotic venous obstruction.
Topics: Adolescent; Adult; Clopidogrel; Factor Xa Inhibitors; Female; Femoral Vein; Follow-Up Studies; Human | 2016 |
1 other study available for ticlopidine and Postthrombotic Syndrome
Article | Year |
---|---|
Prevention of recurrent venous thrombosis and post-thrombotic syndrome.
Topics: Aspirin; Drug Therapy, Combination; Female; Fibrinolytic Agents; Flavonoids; Glycosaminoglycans; Hum | 2018 |